Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
Eur J Pediatr ; 183(6): 2663-2669, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38507064

RESUMEN

Acute bronchiolitis is among the most common causes of hospitalizations in infants worldwide. Associations between weight and severity of respiratory syncytial virus (RSV) bronchiolitis remain unclear. The aim of this study was to evaluate this association. A single-center, retrospective cohort study of infants aged under 24 months, who were hospitalized between 2018 and 2022 for RSV bronchiolitis. Data from computerized medical records were extracted using the MDclone platform. Participants were divided into three groups according to weight percentiles: underweight (below 5th percentile), normal-weight, and overweight (above 85th percentile). A total of 1936 infants (mean age 6.3 months, 55% males) were included, comprising 274 infants who were underweight, 1470 with normal weight, and 192 with overweight. Underweight infants had a higher rate of admission to the pediatric intensive care unit (PICU) (9.1% vs. 3.5%, P < 0.005) and prolonged length of stay (LOS) in the hospital (3.13 vs. 2.79 days P < 0.001) compared to those with normal weight. Hyponatremia was also more common in the underweight group (23% vs. 15%, P < 0.001). A multivariable model accounting for prematurity and birthweight predicted a relative risk of 2.01 (95% CI 1.13-3.48, P = 0.015) for PICU admission and 1.42 (95% CI 1.17-1.7, P < 0.001) for a prolonged LOS. Being overweight was not associated with a more severe disease.  Conclusion: Underweight infants, hospitalized for RSV bronchiolitis, had a more severe disease course with a higher complication rate, including PICU admission and prolonged LOS. Thus, careful attention and supervision should be given to this subgroup of infants. What is Known: • Established risk factors for severe bronchiolitis include prematurity, BPD, CHD, and compromised immunity. • Abnormal weight status has been associated with an increased risk for morbidity and mortality from infectious diseases, proposedly due to the effects on endocrine and immunologic systems. What is New: • Underweight infants hospitalized with RSV bronchiolitis face an independent risk of PICU admission and prolonged hospital stay. • Conversely, overweight infants did not display associations with severity measures in our study.


Asunto(s)
Hospitalización , Infecciones por Virus Sincitial Respiratorio , Humanos , Masculino , Lactante , Estudios Retrospectivos , Femenino , Infecciones por Virus Sincitial Respiratorio/complicaciones , Infecciones por Virus Sincitial Respiratorio/terapia , Hospitalización/estadística & datos numéricos , Bronquiolitis Viral/complicaciones , Bronquiolitis Viral/terapia , Tiempo de Internación/estadística & datos numéricos , Peso Corporal , Delgadez/epidemiología , Recién Nacido , Factores de Riesgo , Índice de Severidad de la Enfermedad , Unidades de Cuidado Intensivo Pediátrico/estadística & datos numéricos
3.
Curr Opin Pediatr ; 27(3): 329-33, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25944313

RESUMEN

PURPOSE OF REVIEW: To reflect the recent advances in the field of pediatric sleep medicine. The pediatrician will be able to define which children to refer for a sleep study and what to expect from the sleep specialist in 2015. RECENT FINDINGS: In the first study that compared adeno tonsillectomy (TA) to watchful waiting, TA reduced symptoms and improved children's behavior, quality of life, and polysomnographic results. Anti-inflammatory therapy for mild obstructive sleep apnea was effective and well tolerated according to a double-blind study. A retrospective study showed that it is beneficial for 80% of the patients. TA is associated with a decrease in asthma symptoms and medication utilization. SUMMARY: Pediatricians need to be aware of the clear benefits of tonsillectomy (including better asthma control), although anti-inflammatory therapy may improve symptoms and polysomnographic findings in children with nonsevere obstructive sleep apnea.


Asunto(s)
Adenoidectomía , Polisomnografía , Calidad de Vida , Apnea Obstructiva del Sueño/cirugía , Tonsilectomía , Espera Vigilante/métodos , Niño , Conducta Infantil , Preescolar , Método Doble Ciego , Humanos , Calidad de Vida/psicología , Estudios Retrospectivos , Apnea Obstructiva del Sueño/complicaciones , Apnea Obstructiva del Sueño/psicología , Resultado del Tratamiento
4.
Mediators Inflamm ; 2014: 146893, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25276051

RESUMEN

BACKGROUND: Obstructive sleep apnea (OSA) is associated with growth impairment that usually improves following effective treatment. In this study we investigated the mechanisms underlying the growth processes in young children diagnosed with OSA, before and after adenotonsillectomy (T&A). METHODS: Young children (6-36 months old) were enrolled and evaluated before and several months after T&A surgery for height, weight, circulating high sensitive C-reactive protein (CRP), and insulin-like growth factor 1 (IGF-1) levels. Caloric intake was assessed by a validated Short Food Frequency Questionnaire (SFFQ). RESULTS: Following T&A, children added 4.81 cm and 1.88 kg to their height and weight, respectively (P < 0.001 for both) and had a significant increase in BMI Z score (P = 0.002). Increased caloric intake of 377 kcal/day was noted (P < 0.001), with increased protein and decreased fat intake. The decrease in CRP levels correlated with the increase in body weight in boys (P < 0.05, adjusted for caloric intake). CONCLUSIONS: Adenotonsillectomy results in enhanced somatic growth in young children that correlates with a decrease in systemic inflammation and caloric intake increment. Our findings imply that systemic inflammation may have an important role in this OSA-related morbidity.


Asunto(s)
Adenoidectomía , Apnea Obstructiva del Sueño/inmunología , Apnea Obstructiva del Sueño/cirugía , Tonsilectomía , Proteína C-Reactiva/metabolismo , Preescolar , Femenino , Humanos , Lactante , Inflamación/inmunología , Inflamación/metabolismo , Masculino , Análisis Multivariante , Polisomnografía , Apnea Obstructiva del Sueño/metabolismo , Encuestas y Cuestionarios , Resultado del Tratamiento
5.
Arch Dis Child ; 109(5): 428-431, 2024 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-38296613

RESUMEN

BACKGROUND: The American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia (PCD) consider the presence of a bi-allelic pathogenic variant confirmatory for the diagnosis of PCD, with genetic testing recommended when other confirmatory diagnostic tests are less accessible. We present our experience with genetic testing as first line with a proposed algorithm for high consanguinity populations. METHODS: Patients with a suspected diagnosis of PCD underwent genetic testing according to a diagnostic algorithm composed of three steps: (1) patients with a previously known causative familial/Bedouin tribal pathogenic variant completed direct testing for a single variant; (2) if the initial test was negative or there was no known pathogenic variant, a PCD genetic panel was completed; (3) if the panel was negative, whole exome sequencing (WES) was completed. RESULTS: Since the implementation of the protocol, diagnosis was confirmed by genetic testing in 21 patients. The majority of them were of Bedouin origin (81%) and had a positive history of consanguinity (65%). Nine patients (43%) had a sibling with a confirmed diagnosis. Most patients (15/21, 71%) were diagnosed by direct pathogenic variant testing and the remainder by genetic panel (19%) and WES (10%). Disease-causing variants were found in nine genes, with DNAL1 (24%) and DNAAF3, DNAAF5, ZMYND10 (14% each) as the most prevalent ones. CONCLUSIONS: In highly consanguineous regions, a stepwise genetic testing approach is recommended. This approach may be particularly useful in areas where the ability to obtain confirmatory diagnostic tests through other modalities is less accessible.


Asunto(s)
Trastornos de la Motilidad Ciliar , Pruebas Genéticas , Humanos , Consanguinidad , Trastornos de la Motilidad Ciliar/diagnóstico , Trastornos de la Motilidad Ciliar/genética , Mutación
6.
Pediatr Pulmonol ; 58(2): 425-432, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36224102

RESUMEN

BACKGROUND: Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, there has been a decline in pediatric emergency department visits. Our aim was to assess the pattern of pediatric foreign body aspiration (FBA) during the first year of the COVID-19 pandemic, in comparison to the prior years. METHODS: In this retrospective multicenter study, we compared the number of children who presented with FBA during the COVID-19 year (March 1, 2020 to February 28, 2021) to the annual average of the years 2016-2019. We also compared the lockdown periods to the postlockdown periods, and the percentage of missed FBA, proven FBA, and flexible bronchoscopy as the removal procedure. RESULTS: A total of 345 children with FBA from six centers were included, 276 in the pre-COVID-19 years (average 69 per year) and 69 in the COVID-19 year. There was no difference in the prevalence of FBA between the COVID-19 year and any of the prior 4 years. Examining the lockdown effect, the monthly incidence of FBA dropped from a pre-COVID-19 average of 5.75 cases to 5.1 cases during lockdown periods and increased to 6.3 cases in postlockdown periods. No difference in the percentage of missed FB or proven FB was observed. There was a significant rise in the usage of flexible bronchoscopy as the removal procedure (average of 15.4% vs. 30.4%, p = 0.001). CONCLUSION: There were fewer cases of pediatric FBA during lockdown periods, compared to post-lockdown periods, presumably related to better parental supervision, with no difference in the prevalence of FBA during the COVID-19 year.


Asunto(s)
COVID-19 , Cuerpos Extraños , Niño , Humanos , Pandemias , Israel/epidemiología , Aspiración Respiratoria/epidemiología , COVID-19/epidemiología , Control de Enfermedades Transmisibles , Broncoscopía/métodos , Estudios Retrospectivos , Cuerpos Extraños/epidemiología
7.
Am J Respir Crit Care Med ; 182(1): 104-12, 2010 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-20224062

RESUMEN

RATIONALE: Exposure to intermittent hypoxia (IH), such as occurs in sleep-disordered breathing, is associated with substantial cognitive impairments, oxidative stress and inflammation, and increased neuronal cell losses in brain regions underlying learning and memory in rats. Physical activity (PA) is now recognized as neuroprotective in models of neuronal injury and degeneration. OBJECTIVES: To examine whether PA will ameliorate IH-induced deficits. METHODS: Young adult Sprague-Dawley rats were randomly assigned to one of four treatment groups including normal activity (NA) or PA for 3 months and then subjected to either normoxia (RA) or exposure to IH during the light phase during the last 14 days. MEASUREMENTS AND MAIN RESULTS: Significant impairments in IH-exposed rats emerged on both latency and pathlength to locate the hidden platform in a water maze and decreased spatial bias during the probe trials. These impairments were not observed in PA-IH rats. In addition, the PA-IH group, relative to NA-IH, conferred greater resistance to both lipid peroxidation and 8-hydroxy-2'-deoxyguanosine (DNA damage) in both the cortex and hippocampus. In support of a neuroprotective effect from PA, PA-IH versus NA-IH rats showed greater AKT activation and neuronal insulin growth factor-1 in these regions. CONCLUSIONS: Behavioral modifications such as increased physical activity are associated with decreased susceptibility to IH-induced spatial task deficits and lead to reduced oxidative stress, possibly through improved preservation of insulin growth factor-1-Akt neuronal signaling. Considering the many advantages of PA, interventional strategies targeting behavioral modifications leading to increased PA should be pursued in patients with sleep-disordered breathing.


Asunto(s)
Terapia por Ejercicio , Hipoxia/complicaciones , Trastornos de la Memoria/etiología , Trastornos de la Memoria/prevención & control , Estrés Oxidativo , Animales , Hipocampo/patología , Hipocampo/fisiopatología , Trastornos de la Memoria/fisiopatología , Condicionamiento Físico Animal , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Ratas Sprague-Dawley
8.
Pediatr Pulmonol ; 56(12): 3983-3990, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34499813

RESUMEN

BACKGROUND: Little known about the prevalence of obstructive sleep apnea (OSA) in morbid obese adolescents and the association between OSA and comorbid factors. AIM: To examine the association between apnea-hypopnea index (AHI, a measure for OSA severity) and metabolic morbidity among morbidly obese adolescents. METHODS: We performed a population-based retrospective cohort study by reviewing sleep study, metabolic indices, and comorbidity-related data of a cohort (n = 106) of adolescents referred to a bariatric surgery clinic. We compared subjects with moderate/severe OSA (AHI ≥ 5) versus no/mild OSA (AHI < 5) OSA and three groups of subjects with increasing body mass index (BMI) concerning sleep-study and metabolic indices using univariate analyses. To assess the link between AHI and ferritin levels a multivariate linear regression (adjusted for BMI and mean cell volume) was preformed. RESULTS: A total of 71 patients met the inclusion criteria. Subjects with moderate/severe OSA (n = 32, 45%) had higher BMI, cholesterol, cholesterol/high-density lipoprotein (HDL) ratio, hemoglobin A1c, and serum ferritin levels (p < .05). AHI significantly increased across BMI strata (p = .02). Multivariate linear regression indicated that moderate/severe OSA was associated with higher levels of ferritin, unstandardized ß = 49.1 (nIU/ml) (p = .025). CONCLUSIONS: Morbidly obese adolescents with moderate/severe OSA versus no/mild OSA have a higher risk for metabolic complications. Therefore, OSA management should be considered in adolescents with morbid obesity, in addition to weight loss.


Asunto(s)
Enfermedades Metabólicas , Obesidad Mórbida , Obesidad Infantil , Apnea Obstructiva del Sueño , Adolescente , Índice de Masa Corporal , Humanos , Enfermedades Metabólicas/epidemiología , Enfermedades Metabólicas/etiología , Obesidad Mórbida/complicaciones , Obesidad Mórbida/epidemiología , Estudios Retrospectivos , Apnea Obstructiva del Sueño/complicaciones , Apnea Obstructiva del Sueño/epidemiología
9.
Sci Rep ; 10(1): 22115, 2020 12 17.
Artículo en Inglés | MEDLINE | ID: mdl-33335174

RESUMEN

Obstructive sleep apnea syndrome (OSA) is associated with cardiovascular morbidity in adults and children. NFκB activity is enhanced in circulating monocytes of adults with OSA, that decreases following positive pressure therapy. OSA children's serum activates NFκB in a cell line. We hypothesized that OSA children's serum can activate NFκB in cardiomyocytes (CM) and effect their viability. In order to explore the role played by NFκB in OSA cardiovascular pathophysiology, rat, mouse and human immortalized CM were exposed to human serum drawn from OSA children and matched controls. Increased expression of NFκB classical subunits p65/p50 as well as major morphological changes occurred in cardiomyocytes following OSA's serum exposure. OSA children's serum induced NFκB activity as measured by p65 nuclear translocation in immortalized human CM and rat cardiomyocytes as well as dense immunostaining of the nucleus. Trypan blue and XTT assays showed that OSA sera induced CM apoptosis. We conclude that NFκB is systemically activated in cardiomyocytes, who also demonstrate decreased viability and contractility following exposure to OSA serum. It supports the hypothesis NFκB plays a role in the evolution of cardiovascular morbidity in OSA. It may support the search for new therapeutic interventions controlling NFκB activation in OSA.


Asunto(s)
Miocitos Cardíacos/metabolismo , FN-kappa B/metabolismo , Apnea Obstructiva del Sueño/metabolismo , Biomarcadores , Niño , Femenino , Humanos , Inmunohistoquímica , Masculino , Transducción de Señal , Apnea Obstructiva del Sueño/complicaciones , Apnea Obstructiva del Sueño/etiología
10.
J Clin Sleep Med ; 16(10): 1731-1735, 2020 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-32638701

RESUMEN

STUDY OBJECTIVES: Rapid-onset obesity with hypothalamic dysregulation, hypoventilation, and autonomic dysregulation (ROHHAD) is a rare condition. Little is known about sleep/wake and slow-wave activity in this condition, although the central hypothalamic dysfunction associated with autonomic dysregulation would make the occurrence of SWA deregulation most likely. METHODS: Two children with clinical presentation of ROHHAD syndrome were evaluated, diagnosed, and treated. Their polysomnographic studies were compared with 4 matched children with obstructive sleep apnea and 6 controls. RESULTS: Children that were clinically diagnosed with ROHHAD exhibited significantly weaker slow-wave activity power and shallower slow-wave activity slopes during the first 2 sleep cycles compared with children with obstructive sleep apnea or controls. CONCLUSIONS: This study shows that children with ROHHAD have suppressed slow-wave activity, possibly because of hypothalamic dysregulation that may contribute to their rapid-onset obesity and excessive daytime sleepiness.


Asunto(s)
Enfermedades del Sistema Nervioso Autónomo , Enfermedades Hipotalámicas , Síndrome de Hipoventilación por Obesidad , Sueño de Onda Lenta , Enfermedades del Sistema Nervioso Autónomo/complicaciones , Niño , Humanos , Enfermedades Hipotalámicas/complicaciones , Hipoventilación/complicaciones , Obesidad/complicaciones
11.
Obes Res Clin Pract ; 14(6): 542-547, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33189604

RESUMEN

OBJECTIVES: To assess the association between sleep disorders prevalence and obesity in Israeli adolescents. METHODS: A nationwide, population-based, cross-sectional study of 1,348,817 Israeli adolescents (57% males) who were medically examined prior to military service between 1997 and 2015; height and weight were measured along with assessment of medical status at age 17.3⬰±â¬°0.4 years. The diagnosis of a sleep disorder was made based on objective diagnostic criteria. The prevalence and odds ratio (OR) for a sleep disorder were computed across BMI subgroups and were adjusted for socio-demographic confounders. RESULTS: Overall sleep disorders prevalence was 1.8:1000 (males) and 0.45:1000 (females), with a total of 1601 cases. There was a gradual increase in the odds ratio for sleep disorders with increasing BMI. Multivariable-adjusted ORs for sleep disorders were 1.29 (95% CI 1.10⬜1.52), 1.44 (1.18⬜1.75), 3.03 (2.32⬜3.96) and 3.38 (1.98⬜5.75) for overweight, obese class I, II and III, respectively (5th⬜49th BMI percentile was the reference). Results persisted in extensive sensitivity analyses including limiting the study sample to participants with unimpaired health. CONCLUSIONS: We found a higher prevalence of sleep disorders in males and a dose-dependent association between sleep disorders and adolescent BMI in both sexes. Our findings warrant clinical awareness among healthcare providers, given the rise in obesity in teenagers, and particularly in light of the obesity epidemic that we are experiencing in this era. Sleep related complaints should be actively screened in adolescents who suffer obesity.


Asunto(s)
Obesidad , Trastornos del Sueño-Vigilia , Adolescente , Índice de Masa Corporal , Estudios Transversales , Femenino , Humanos , Masculino , Sobrepeso , Prevalencia
12.
Am J Respir Crit Care Med ; 177(10): 1135-41, 2008 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-18276944

RESUMEN

RATIONALE: The intermittent hypoxia (IH) that characterizes sleep-disordered breathing impairs spatial learning and increases NADPH oxidase activity and oxidative stress in rodents. We hypothesized that green tea catechin polyphenols (GTPs) may attenuate IH-induced neurobehavioral deficits by reducing IH-induced NADPH oxidase expression, lipid peroxidation, and inflammation. OBJECTIVES: To assess the effects of GTP administered in drinking water on the cognitive, inflammatory, and oxidative responses to long-term (>14 d) IH during sleep in male Sprague-Dawley rats. METHODS: Cognitive assessments were conducted in the Morris water maze. We measured levels and expression of malondialdehyde (MDA), prostaglandin E(2), p47(phox) subunit of NADPH oxidase, receptor for advanced glycation end products (RAGE), and glial fibrillary acidic protein expression in rodent brain tissue. MEASUREMENTS AND MAIN RESULTS: GTP treatment prevented IH-induced decreases in spatial bias for the hidden platform during the Morris water maze probe trails as well as IH-induced increases in p47phox expression within the hippocampal CA1 region. In untreated animals, IH exposure was associated with doubling of cortical MDA levels in comparison to room air control animals, and GTP-treated animals exposed to IH showed a 40% reduction in MDA levels. Increases in brain RAGE and glial fibrillary acidic protein expression were observed in IH-exposed animals, and these increases were attenuated in animals treated with GTP. CONCLUSIONS: Oral GTP attenuates IH-induced spatial learning deficits and mitigates IH-induced oxidative stress through multiple beneficial effects on oxidant pathways. Because oxidative processes underlie neurocognitive deficits associated with IH, the potential therapeutic role of GTP in sleep-disordered breathing deserves further exploration.


Asunto(s)
Catequina/farmacología , Cognición/efectos de los fármacos , Hipoxia/psicología , Aprendizaje por Laberinto/efectos de los fármacos , Extractos Vegetales/farmacología , Síndromes de la Apnea del Sueño/psicología , Animales , Modelos Animales de Enfermedad , Hipocampo/efectos de los fármacos , Hipoxia/etiología , Peroxidación de Lípido/efectos de los fármacos , Masculino , NADPH Oxidasas/efectos de los fármacos , NADPH Oxidasas/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Síndromes de la Apnea del Sueño/complicaciones , Té/química
13.
BMC Pulm Med ; 9: 12, 2009 Apr 14.
Artículo en Inglés | MEDLINE | ID: mdl-19366453

RESUMEN

BACKGROUND: Nonattendance for scheduled appointments disturbs the effective management of pediatric pulmonary clinics. We hypothesized that the reasons for non-attendance and the necessary solutions might be different in pediatric pulmonary medicine than in other pediatric fields. We therefore investigated the factors associated with nonattendance this field in order to devise a corrective strategy. METHODS: The effect of age, gender, ethnic origin, waiting time for an appointment and the timing of appointments during the day on nonattendance proportion were assessed. Chi-square tests were used to analyze statistically significant differences of categorical variables. Logistic regression models were used for multivariate analysis. RESULTS: A total of 1190 pediatric pulmonology clinic visits in a 21 month period were included in the study. The overall proportion of nonattendance was 30.6%. Nonattendance was 23.8% when there was a short waiting time for an appointment (1-7 days) and 36.3% when there was a long waiting time (8 days and above) (p-value < 0.001). Nonattendance was 28.7% between 8 a.m. to 3 p.m. and 37.5% after 3 p.m. (p = 0.007). Jewish rural patients had 15.4% nonattendance, Jewish urban patients had 31.2% nonattendance and Bedouin patients had 32.9% nonattendance (p < 0.004). Age and gender were not significantly associated with nonattendance proportions. A multivariate logistic regression model demonstrated that the waiting time for an appointment, time of the day, and the patients' origin was significantly associated with nonattendance. CONCLUSION: The factors associated with nonattendance in pediatric pulmonary clinics include the length of waiting time for an appointment, the hour of the appointment within the day and the origin of the patient.


Asunto(s)
Citas y Horarios , Enfermedades Pulmonares/terapia , Visita a Consultorio Médico/estadística & datos numéricos , Servicio Ambulatorio en Hospital/estadística & datos numéricos , Negativa del Paciente al Tratamiento/estadística & datos numéricos , Niño , Femenino , Humanos , Israel/epidemiología , Enfermedades Pulmonares/epidemiología , Masculino , Prevalencia
14.
Pediatr Pulmonol ; 53(1): 95-102, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29178284

RESUMEN

AIM: The aims of this pilot study were to determine safety, tolerability (primary outcome) and efficacy (secondary outcome) of high-dose inhaled nitric oxide for the treatment of infants with moderately severe bronchiolitis. METHODS: This was a pilot, double-blinded, randomized controlled study (phase IIa). Intermittent inhalations of nitric oxide 160 ppm for 30 min or oxygen/air (control) were given 5 times/day to hospitalized infants (2-11 months) with acute bronchiolitis. Oxygen saturation, methemoglobin, and nitric dioxide (NO2 ) levels and vital signs were monitored. RESULTS: Forty-three infants were enrolled. Baseline characteristics were comparable in both study groups. Mean clinical score, comprised of four components: respiratory rate, use of accessory muscles, wheezes and crackles, and % room-air oxygen saturation, was 7.86 (±1.1) and 8.09 (±1.2) in the NO and control groups, respectively, consistent with moderate severity. The overall frequency of adverse events was similar between the groups. Repeated nitric oxide inhalations did not result in increased inhaled NO2 levels or cumulative effect on methemoglobin levels. Secondary outcomes of efficacy were measured by length of hospitalization (LOS) in hours: LOS did not differ between groups. However, in a post-hoc analysis of a subgroup of infants hospitalized for >24 h (n = 24), the median LOS was shorter in the nitric oxide (41.9 h) than in the control group (62.5 h) (P = 0.014). CONCLUSION: Our study was unable to detect a difference in side effects using intermittent high-dose nitric-oxide inhalation or supportive treatment alone, in infants with moderate bronchiolitis. Preliminary efficacy outcomes are encouraging.


Asunto(s)
Bronquiolitis/tratamiento farmacológico , Óxido Nítrico/uso terapéutico , Administración por Inhalación , Bronquiolitis/sangre , Método Doble Ciego , Femenino , Hospitalización , Humanos , Lactante , Masculino , Metahemoglobina/metabolismo , Óxido Nítrico/administración & dosificación , Oxígeno/metabolismo , Proyectos Piloto , Frecuencia Respiratoria
15.
Sleep ; 30(4): 443-9, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17520788

RESUMEN

STUDY OBJECTIVE: Associations between SDB, the metabolic syndrome, and circulating levels of adipokines have emerged in adults but have not been examined in snoring children, who, in contradistinction to adults, display insulin resistance and lipid abnormalities as a function of adiposity rather than SDB. Therefore, we aimed to examine associations between circulating adipokines levels, insulin resistance, and measures of SDB in children. DESIGN: Prospective study. SETTING: Polysomnographic evaluation and assessment of plasma levels of leptin, adiponectin, resistin, glucose, insulin, and CRP. PARTICIPANTS: 130 children (mean age 8.2 +/- 2.8 years; 39% obese) were studied. MEASUREMENTS AND RESULTS: Log adiponectin levels were lower in obese than nonobese children (3.8 +/- 0.31 vs 4.0 +/- 0.30 corresponding to 8,381.4 +/- 5,841.0 vs 12,853.2 +/- 7,780.2 ng/ml, P < 0.0001) and were inversely correlated with BMI Z scores (r = -0.47, P < 0.0001) but not with log AHI. Log leptin concentrations were higher in the obese group than the nonobese group (4.2 +/- 0.32 vs 3.4 +/- 0.57 corresponding to 19,542.6 +/- 13,643.6 vs 5,875.5 +/- 8,425.7 pg/ml, P < 0.0001), correlated with BMI Z scores (r = 0.64, P < 0.0001), and were significantly lower in children with AHI < or = 1/hr than children with AHI > 1/hr (P = 0.006) and in children with SpO2 nadir > or = 90% than children with SpO2 nadir < 90%, even after controlling for BMI Z score (P < 0.03). No significant differences were found in log resistin levels as a function of obesity or AHI. Significant correlations between log adiponectin levels and log Insulin/Glucose (I/G) ratios (-0.28, P = 0.006) and between log leptin levels and log I/G ratios (r = 0.66, P < 0.0001) emerged. CONCLUSIONS: In close agreement with the absence of a measurable effect of SDB on insulin resistance in children, circulating adipokines levels are primarily attributable to the ponderal index. However, SDB and associated hypoxemia may contribute to the elevation of leptin levels.


Asunto(s)
Hormonas de Insectos/sangre , Oligopéptidos/sangre , Ácido Pirrolidona Carboxílico/análogos & derivados , Apnea Obstructiva del Sueño/sangre , Adolescente , Glucemia/metabolismo , Índice de Masa Corporal , Proteína C-Reactiva/metabolismo , Niño , Preescolar , Femenino , Humanos , Lactante , Insulina/sangre , Resistencia a la Insulina/fisiología , Leptina/sangre , Masculino , Síndrome Metabólico/sangre , Síndrome Metabólico/diagnóstico , Obesidad/sangre , Polisomnografía , Ácido Pirrolidona Carboxílico/sangre , Resistina/sangre , Factores de Riesgo , Apnea Obstructiva del Sueño/diagnóstico , Estadística como Asunto
16.
Isr Med Assoc J ; 9(11): 806-9, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18085039

RESUMEN

BACKGROUND: Rehabilitation camps can improve exercise tolerance and nutrition in cystic fibrosis patients. OBJECTIVES: To assess weight gain, pulmonary function tests and daily symptoms in European CF patients attending a rehabilitation camp at the Dead Sea, Israel. METHODS: We conducted a retrospective study assessing 94 CF patients who participated in winter camps held at the Dead Sea, Israel from 1997 to 2000. The camp program included daily physiotherapy, physical activities, and a high caloric diet. We assessed weight gain, pulmonary function tests, oxyhemoglobin saturation and daily symptoms before (pre), on departure (dep), and up to 3 months after the 3 week rehabilitation camp (post). All data were analyzed by ANOVA for repetitive measurements. P < 0.05 was considered significant. RESULTS: Lung function tests and oxyhemoglobin saturation taken before, on departure and 3 months after camp were available for 35 patients. Forced expiratory volume in the first second (% predicted, average +/- SD) improved by 8.2 +/- 2.3% (pre, dep, post, P < 0.05). Oxyhemoglobin saturation mildly improved (1 +/- 0.3%, pre, dep, post, P < 0.05). Forced vital capacity (% predicted) increased by 3.9 +/- 1.2%, but was not significant (P = 0.19). Total body weight of 89 patients improved by 1.9 +/- 0.9% during the camp time (P < 0.05, t-test), and in a group of 24 patients weight continuously increased up to 5.0 +/- 1.7% at 3 months after the camp (P = 0.004, ANOVA). CONCLUSIONS: In this attrition-limited retrospective study, European CF patients improved their pulmonary function and gained weight during and up to 3 months after a 3 week rehabilitation winter camp at the Dead Sea, Israel.


Asunto(s)
Fibrosis Quística/rehabilitación , Recreación , Adolescente , Adulto , Altitud , Niño , Preescolar , Fibrosis Quística/fisiopatología , Femenino , Humanos , Israel , Masculino , Océanos y Mares , Oxihemoglobinas/análisis , Pruebas de Función Respiratoria , Estudios Retrospectivos , Capacidad Vital
17.
Chest ; 130(1): 143-8, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16840394

RESUMEN

BACKGROUND: Upper airway inflammation is now recognized in adults with obstructive sleep apnea (OSA) syndrome. However, the role played by eicosanoids such as leukotrienes and prostaglandins is unclear. OBJECTIVE: To investigate whether eicosanoids are measurable in exhaled breath condensate (EBC), and to determine whether differences in these inflammatory mediators emerge among children with and without sleep-disordered breathing (SDB). METHODS: EBC was collected from 50 consecutive snoring children undergoing overnight polysomnography for suspected SDB, and from 12 nonsnoring control subjects. Prostaglandin E2 (PGE2), leukotriene B4 (LTB4), and cysteinyl leukotrienes (cys-LTs: leukotriene C4 [LTC4]/leukotriene D4 [LTD4]/leukotriene E4 [LTE4]) EBC levels were analyzed using enzyme-linked immunosorbent assay. RESULTS: LTB4 levels were elevated in children with an apnea-hypopnea index (AHI) > 5/h (SDB; 97.6 +/- 6.3 pg/mL) compared to children with an AHI < 5/h (mild SDB; 66.4 +/- 19.1 pg/mL; p < 0.01) and control subjects (27.8 +/- 3.7 pg/mL; p < 0.01). Similarly, cys-LT (LTC4/LTD4/LTE4) concentrations were also increased in SDB (45.1 +/- 10.6 pg/mL in SDB vs 27.6 +/- 8.3 pg/mL in mild SDB, and 15.7 +/- 7.6 pg/mL in control subjects; p < 0.01). In contrast, PGE2 concentrations were similar among the three groups. CONCLUSIONS: Inflammatory mediators such as leukotrienes and prostaglandins can be readily quantified in EBC collected from the upper airway of children. Disease severity-dependent increases in leukotriene concentrations (LTB4 and LTC4/LTD4/LTE4) emerge among children and may serve as a noninvasive tool in the clinical assessment of these children.


Asunto(s)
Pruebas Respiratorias/métodos , Eicosanoides/clasificación , Apnea Obstructiva del Sueño/clasificación , Adolescente , Pruebas Respiratorias/instrumentación , Niño , Eicosanoides/aislamiento & purificación , Eicosanoides/metabolismo , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Masculino , Polisomnografía , Índice de Severidad de la Enfermedad , Apnea Obstructiva del Sueño/metabolismo , Ronquido
18.
Pediatr Pulmonol ; 50(2): 187-95, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24574078

RESUMEN

BACKGROUND: Early life viral infection is associated with neurogenic inflammation that is present in lymphoid tissues of the upper airway in children with obstructive sleep apnea (OSA). We hypothesized that viral genomic material is present in tonsils of children with OSA. Therefore, we examined tonsils for the presence of respiratory viruses' nucleic acids in children with OSA, and in children without OSA (undergoing surgery for recurrent throat infections (RI)). METHODS: Tonsillar tissue from patients with OSA and RI was subjected to multiplex quantitative real time reverse transcription PCR (mqRTPCR), analyzed for the presence of common respiratory viruses' genetic material. RESULTS: Fifty-six patients were included, of whom 34 had OSA (age (years ± S.D), 4.22 ± 1.14) and 22 with RI (4.35 ± 1.36). Respiratory viruses nucleic acids (24 detections) were observed in 17 (50%) OSA samples. In contrast, no virus was detected in RI samples (relative frequency P<0.0001). Viruses detected, based on frequency were Rhinovirus, Adenovirus, human metapneumovirus (hMPV), respiratory syncytial virus (RSV), and corona virus. CONCLUSIONS: Respiratory viruses are detected in OSA hypertrophic tonsils, suggestive of their role in the evolution of tonsillar inflammation and hypertrophy. Early life viral infections may contribute to the pathogenesis of pediatric OSA.


Asunto(s)
Tonsila Palatina/virología , Apnea Obstructiva del Sueño/cirugía , Niño , Preescolar , ADN Viral/genética , Femenino , Humanos , Hipertrofia , Masculino , Tonsila Palatina/patología , Reacción en Cadena de la Polimerasa , ARN Viral/genética , Tonsilectomía
19.
Chest ; 126(1): 13-8, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15249436

RESUMEN

BACKGROUND: Recurrent tonsillitis and sleep apnea are the major indications for tonsillectomy in children. We hypothesized that the recurrent vibration in the upper airway of snoring children would promote inflammatory changes in the tonsillar tissue and would lead to the up-regulation of cysteinyl leukotriene (LT) receptors (Rs). OBJECTIVE: To assess the expression patterns of the human LT-Rs in children undergoing tonsillectomy, and compare those patterns in children having recurrent throat infections (RIs) and children with obstructive sleep apnea syndrome (SA). METHODS: Tonsillar tissue from 17 children with SA and 13 with RIs was subjected to quantitative polymerase chain reaction using specific primers for LT1-R and LT2-R, and to immunohistochemistry and Western blotting for protein expression of LT1-R and LT2-R. RESULTS: Messenger RNA encoding for the expression of LT1-R and LT2-R was detected in the tonsils of all children. Immunoblots revealed significantly higher expressions of LT1-R and LT2-R in the tonsils of children with SA. The topographic pattern of both receptors differed among the tonsils of children with SA and RI. CONCLUSION: LT1-R and LT2-R are expressed in pediatric tonsillar tissue, are more abundant in SA patients, and demonstrate a specific topographic pattern of expression. These findings suggest that an inflammatory process involving LT expression and regulation occurs in children with SA.


Asunto(s)
Proteínas de la Membrana/aislamiento & purificación , Receptores de Leucotrienos/aislamiento & purificación , Apnea Obstructiva del Sueño/fisiopatología , Tonsilitis/fisiopatología , Niño , Preescolar , Femenino , Humanos , Masculino , Proteínas de la Membrana/genética , Receptores de Leucotrienos/genética , Recurrencia , Apnea Obstructiva del Sueño/etiología , Apnea Obstructiva del Sueño/cirugía , Tonsilectomía , Tonsilitis/complicaciones , Tonsilitis/cirugía , Regulación hacia Arriba
20.
Expert Opin Investig Drugs ; 22(1): 71-85, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23126687

RESUMEN

INTRODUCTION: The lymphadenoid tissues in the upper airway are sparse and organized lympho-epithelial structures playing an important role against foreign pathogens, with the palatine tonsils being the major components of the lymphoid tissues contained in the Waldeyer's ring. Obstructive sleep apnea (OSA) has emerged as a very frequent condition in the pediatric age range that is associated with substantial neurobehavioral, cardiovascular and metabolic morbidities. Adenotonsillar hypertrophy is the major pathophysiological contributor to OSA occurrence in children. AREAS COVERED: Here, the authors provide a systematic review and summary of some of the known histological and pathological features of human lymphadenoid tissues and their fundamental immunological functions, provide insights into the pathophysiology of pediatric OSA, particularly focusing on inflammatory pathways and the available outcomes associated with targeting such pathways with compounds such as corticosteroids and leukotriene modifiers. Furthermore, they present findings from an unbiased approach to discovery of therapeutic targets and formulate constructs toward putative future interventional approaches for this highly prevalent condition. EXPERT OPINION: Surgical approaches for pediatric OSA may not be as effective as previously anticipated. Accordingly, expanded use of existing systemic or topical anti-inflammatory agents or development of novel compounds targeting selected immune cell populations underlying pathophysiological determinants of OSA is needed.


Asunto(s)
Apnea Obstructiva del Sueño/tratamiento farmacológico , Antiinflamatorios/uso terapéutico , Niño , Humanos , Inflamación/tratamiento farmacológico , Inflamación/inmunología , Leucotrienos/inmunología , Tejido Linfoide/inmunología , Receptores de Leucotrienos/inmunología , Apnea Obstructiva del Sueño/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA